Benzinga's Top Pre-Market NASDAQ Gainers (AVNR, FTNT, YRCW, ORCT)

Avanir Pharmaceuticals Inc 0AVNR rose 131.82% to $5.61 in the pre-market session. US FDA has given its approval to AVNR's involuntary emotion drug Nuedexta. Fortinet Inc FTNT added 29.97% to $38.99 in the pre-market session. According to the Bloomberg, FTNT received a takeover approach from International Business Machines Corp IBM. YRC Worldwide Inc YRCW soared 29.25% to $5.70 in the pre-market trading. The union workers of YRCW have approved a 3rd round of concessions. Orckit Communications Limited ORCT moved up 12.90% to $3.85 in the pre-market session. ORCT has been awarded with a additional multi million purchase order for immediate deployment of CM-4000 products in Bharat Sanchar Nigam Limited (BSNL) in India. Read more from Benzinga's Markets.